about
Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET ImagingImmuno-PET for Clinical Theranostic Approaches.PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.Radiolabeled antibodies for cancer imaging and therapy.Radioimmunoconjugates for treating cancer: recent advances and current opportunities.Radioimmunotherapy for Treatment of Acute Leukemia.213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
P50
Q26784016-3711C44E-B50A-4DE1-995C-BA989DA4E088Q37631461-416D1E07-9973-49BA-92B5-8571FC5D78C6Q37691050-3FFA2A98-9F28-4623-8CD3-781FCF8AC109Q37973297-17D1BA1C-CF7D-4B37-ACFC-2369EA45A5EFQ38036119-063583FB-7978-4265-884E-58CD77A5C616Q38691472-22C68A0A-9779-48A1-83C9-C797142CC60EQ38742247-76B5DBBD-6261-4E57-9915-9F9F396B5D1EQ39100459-9FB075C2-75BD-4F87-84B3-3140DC0F50C2
P50
description
onderzoeker
@nl
name
Mickaël Bourgeois
@ast
Mickaël Bourgeois
@en
Mickaël Bourgeois
@sl
type
label
Mickaël Bourgeois
@ast
Mickaël Bourgeois
@en
Mickaël Bourgeois
@sl
altLabel
Mickael Bourgeois
@en
prefLabel
Mickaël Bourgeois
@ast
Mickaël Bourgeois
@en
Mickaël Bourgeois
@sl